The objective of this study was to analyze the characteristics that contribute to the successful dissemination of VIM-producing Pseudomonas aeruginosa (P. aeruginosa), belonging to ST111 and ST235, in a Greek hospital. A total of 120 non-repetitive P. aeruginosa, which had meropenem minimal inhibitory concentrations (MICs) greater than 2 mg/L, were studied. VIM-encoding genes were amplified and sequenced within their integrons. Isolates were typed by multilocus sequence typing (MLST). Six VIM-producers, representative of different integron structures and sequence types (STs), were completely sequenced using Illumina platform. Sixty-one P. aeruginosa were confirmed to produce VIM-type carbapenemases. ST111 dominated (n = 34) among VIM-producers, while 15 VIM-producers belonged to ST235. The blaVIM-like genes were located in three integron types, including In59, In595 and In1760, which were integrated into P. aeruginosa chromosomes. Whole genome sequencing (WGS) data demonstrated that ST111 and ST235 MBL producers carried several resistance and virulence genes. Additionally, the presence of type I-C and type I-E clustered regularly interspaced short palindromic repeats (CRISPR)/Cas locus was observed in ST235 and ST395 isolates, respectively. In conclusion, our findings confirmed the clonal spread of ST111 P. aeruginosa, carrying the VIM-2-encoding integron In59, in the University Hospital of Larissa (UHL). In addition, they highlighted the important role of high-risk clones, ST111 and ST235, in the successful dissemination and establishment into hospital settings of clinically important pathogens carrying resistance determinants.

Biomedical Center Faculty of Medicine Charles University 32300 Pilsen Czech Republic

Department of Microbiology University Hospital of Larissa 41110 Larissa Greece

Zobrazit více v PubMed

Nicolle L.E. Complicated urinary tract infection in adults. Can. J. Infect. Dis. Med. 2005;16:349–360. doi: 10.1155/2005/385768. PubMed DOI PMC

WHO Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. [(accessed on 27 February 2020)];2017 Available online: http://www.who.int/medicines/publications/global-prioritylist-antibiotic-resistant-bacteria/en/

Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clin. Infect. Dis. 2002;34:634–640. doi: 10.1086/338782. PubMed DOI

Tzouvelekis L.S., Markogiannakis A., Psichogiou M., Tassios P.T., Daikos G.L. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: An evolving crisis of global dimensions. Clin. Microbiol. Rev. 2012;25:682–707. doi: 10.1128/CMR.05035-11. PubMed DOI PMC

Tsakris A., Pournaras S., Woodford N., Palepou M.F., Babini G.S., Douboyas J., Livermore D.M. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 2000;38:1290–1292. doi: 10.1128/JCM.38.3.1290-1292.2000. PubMed DOI PMC

Giakkoupi P., Petrikkos G., Tzouvelekis L.S., Tsonas S., Legakis N.J., Vatopoulos A.C., WHONET Greece Study Group Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals. J. Clin. Microbiol. 2003;41:822–825. doi: 10.1128/JCM.41.2.822-825.2003. PubMed DOI PMC

Pournaras S., Tsakris A., Maniati M., Tzouvelekis L.S., Maniatis A.N. Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2002;46:4026–4028. doi: 10.1128/AAC.46.12.4026-4028.2002. PubMed DOI PMC

Pournaras S., Maniati M., Petinaki E., Tzouvelekis L.S., Tsakris A., Legakis N.J., Maniatis A.N. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4. J. Antimicrob. Chemother. 2003;51:1409–1414. doi: 10.1093/jac/dkg239. PubMed DOI

Liakopoulos A., Mavroidi A., Katsifas E.A., Theodosiou A., Karagouni A.D., Miriagou V., Petinaki E. Carbapenemase-producing Pseudomonas aeruginosa from Central Greece: Molecular epidemiology and genetic analysis of class I integrons. BMC Infect. Dis. 2013;13:505. doi: 10.1186/1471-2334-13-505. PubMed DOI PMC

EUCAST European Committee on Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect. 2003;9:ix–xv. doi: 10.1046/j.1469-0691.2003.00790.x. PubMed DOI

Wayne P.A. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2013. CLSI 2013, 23rd International Supplement, CLSI document M100-S23.

Lee K., Lim Y.S., Yong D., Yum J.H., Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-b-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 2003;41:4623–4629. doi: 10.1128/JCM.41.10.4623-4629.2003. PubMed DOI PMC

Papagiannitsis C.C., Medvecky M., Chudejova K., Skalova A., Rotova V., Spanelova P., Jakubu V., Zemlickova H., Hrabak J. Molecular Characterization of carbapenemase-producing Pseudomonas aeruginosa of Czech origin and evidence for clonal spread of extensively resistant Sequence Type 357 expressing IMP-7 metallo-β-lactamase. Antimicrob. Agents Chemother. 2017;61:e01811-17. doi: 10.1128/AAC.01811-17. PubMed DOI PMC

Curran B., Jonas D., Grundmann H., Pitt T., Dowson C.G. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 2004;42:5644–5649. doi: 10.1128/JCM.42.12.5644-5649.2004. PubMed DOI PMC

Moura A., Soares M., Pereira C., Leitão N., Henriques I., Correia A. INTEGRALL: A database and search engine for integrons, integrases and gene cassettes. Bioinformatics. 2009;25:1096–1098. doi: 10.1093/bioinformatics/btp105. PubMed DOI

Barton B.M., Harding G.P., Zuccarelli A.J. A general method for detecting and sizing large plasmids. Anal. Biochem. 1995;226:235–240. doi: 10.1006/abio.1995.1220. PubMed DOI

Zankari E., Hasman H., Cosentino S., Vestergaard M., Rasmussen S., Lund O., Aarestrup F.M., Larsen M.V. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012;67:2640–2644. doi: 10.1093/jac/dks261. PubMed DOI PMC

Liu B., Zheng D.D., Jin Q., Chen L.H., Yang J. VFDB 2019: A comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. 2019;47:D687–D692. doi: 10.1093/nar/gky1080. PubMed DOI PMC

Couvin D., Bernheim A., Toffano-Nioche C., Touchon M., Michalik J., Neron B., Rocha E.P.C., Vergnaud G., Gautheret D., Pourcel C. CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins. Nucleic Acids Res. 2018;46:W246–W251. doi: 10.1093/nar/gky425. PubMed DOI PMC

Woodford N., Turton J.F., Livermore D.M. Multiresistant Gram-negative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 2011;35:736–755. doi: 10.1111/j.1574-6976.2011.00268.x. PubMed DOI

Poirel L., Lambert T., Turkoglu S., Ronco E., Gaillard J.L., Nordmann P. Characterization of class 1 integrons from Pseudomonas aeruginosa that contain the blaVIM-2 carbapenem-hydrolyzing b-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob. Agents Chemother. 2001;45:546–552. doi: 10.1128/AAC.45.2.546-552.2001. PubMed DOI PMC

Samuelsen Ø., Toleman M.A., Sundsfjord A., Rydberg J., Leegaard T.M., Walder M., Lia A., Ranheim T.E., Rajendra Y., Hermansen N.O., et al. Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob. Agents Chemother. 2010;54:346–352. doi: 10.1128/AAC.00824-09. PubMed DOI PMC

Yano H., Genka H., Ohtsubo Y., Nagata Y., Top E.M., Tsuda M. Cointegrate-resolution of toluene-catabolic transposon Tn4651: Determination of crossover site and the segment required for full resolution activity. Plasmid. 2013;69:24–35. doi: 10.1016/j.plasmid.2012.07.004. PubMed DOI

Breidenstein E.B.M., de la Fuente-Nunez C., Hancock R.E.W. Pseudomonas aeruginosa: All roads lead to resistance. Trends Microbiol. 2011;19:419–426. doi: 10.1016/j.tim.2011.04.005. PubMed DOI

Jalal S., Wretlind B. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microb. Drug Resist. 1998;4:257–261. doi: 10.1089/mdr.1998.4.257. PubMed DOI

Walsh F., Amyes S.G. Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J. Chemother. 2007;19:376–381. doi: 10.1179/joc.2007.19.4.376. PubMed DOI

Lanotte P., Watt S., Mereghetti L., Dartiguelongue N., Rastegar-Lari A., Goudeau A., Quentin R. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J. Med. Microbiol. 2004;53:73–81. doi: 10.1099/jmm.0.05324-0. PubMed DOI

Azimi S., Kafil H.S., Baghi H.B., Shokrian S., Najaf K., Asgharzadeh M., Yousefi M., Shahrivar F., Aghazadeh M. Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran. GMS Hyg. Infect. Control. 2016;11:Doc04. doi: 10.3205/dgkh000264. PubMed DOI PMC

Roy-Burman A., Savel R.H., Racine S., Revadigar N.S., Fujimoto J., Sawa T., Frank D.W., Wiener-Kronish J.P. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 2001;183:1767–1774. doi: 10.1086/320737. PubMed DOI

Finck-Barbancon V., Goranson J., Zhu L., Wiener-Kronish J.P., Fleiszig S.M., Wu C., Mende-Mueller L., Frank D.W. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 1997;25:547–557. doi: 10.1046/j.1365-2958.1997.4891851.x. PubMed DOI

Van’t Wout E.F., Van Schadewijk A., Van Boxtel R., Dalton L.E., Clarke H.J., Tommassen J., Marciniak S.J., Hiemstra P.S. Virulence factors of Pseudomonas aeruginosa induce both the unfolded protein and integrated stress responses in airway epithelial cells. PLoS Pathog. 2015;11:e1004946. doi: 10.1371/journal.ppat.1004946. PubMed DOI PMC

Jamunadevi S., Balashanmugam P., Muralitharan G., Kalaichelvan P.T. Molecular characterization of pathogenic and non-pathogenic Pseudomonas aeruginosa with special reference to phenazine gene. J. Mod. Biotechnol. 2012;1:70–74.

Karah N., Samuelsen O., Zarrilli R., Sahl J.W., Wai S.N., Uhlin B.E. CRISPR-cas subtype I-Fb in Acinetobacter baumannii: Evolution and utilization for strain subtyping. PLoS ONE. 2015;10:e0118205. doi: 10.1371/journal.pone.0118205. PubMed DOI PMC

van Belkum A., Soriaga L.B., LaFave M.C., Akella S., Veyrieras J.B., Barbu E.M., Shortridge D., Blanc B., Hannum G., Zambardi G., et al. Phylogenetic distribution of CRISPR-Cas systems in antibiotic-resistant Pseudomonas aeruginosa. mBio. 2015;6:e01796-15. doi: 10.1128/mBio.01796-15. PubMed DOI PMC

de Oliveira Luz A.C., da Silva J.M.A., Rezende A.M., de Barros M.P.S., Leal-Balbino T.C. Analysis of direct repeats and spacers of CRISPR/Cas systems type I-F in Brazilian clinical strains of Pseudomonas Aeruginosa. Mol. Genet. Genom. 2019;294:1095–1105. doi: 10.1007/s00438-019-01575-7. PubMed DOI

Wright L.L., Turton J.F., Hopkins K.L., Livermore D.M., Woodford N. Genetic environment of metallo-β-lactamase genes in Pseudomonas aeruginosa isolates from the UK. J. Antimicrob. Chemother. 2015;70:3250–3258. doi: 10.1093/jac/dkv263. PubMed DOI

Ostria-Hernandez M.L., Sánchez-Vallejo C.J., Ibarra J.A., Castro-Escarpulli G. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae. BMC Res. Notes. 2015;8:332. doi: 10.1186/s13104-015-1285-7. PubMed DOI PMC

Hatoum-Aslan A., Marraffini L.A. Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens. Curr. Opin. Microbiol. 2014;17:82–90. doi: 10.1016/j.mib.2013.12.001. PubMed DOI PMC

Edelstein M.V., Skleenova E.N., Shevchenko O.V., D’souza J.W., Tapalski D.V., Azizov I.S., Sukhorukova M.V., Pavlukov R.A., Kozlov R.S., Toleman M.A., et al. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: A longitudinal epidemiological and clinical study. Lancet Infect. Dis. 2013;13:867–876. doi: 10.1016/S1473-3099(13)70168-3. PubMed DOI

Hrabak J., Bitar I., Papagiannitsis C.C. Combination of mass spectrometry and DNA sequencing for detection of antibiotic resistance in diagnostic laboratories. Folia Microbiol. 2020;65:233–243. doi: 10.1007/s12223-019-00757-5. PubMed DOI